Veefin Promoters Fully Convert Share Warrants, Infusing Rs. 8.43 Cr to Fuel Global Growth

Mumbai (Maharashtra) [India], August 11: Veefin Solutions Limited(BSE: VEEFIN | 543931), a leading technology enabler building the world’s largest working capital ecosystem, today announced the successful receipt of the final subscription amount for share warrants issued to its promoters. This marks the completion of the ₹8.43 crore capital infusion through the conversion of 4,20,000 convertible warrants into equity shares.

The warrants, originally allotted in March 2024, were subscribed by promoters Mr. Raja Debnath and Mr. Gautam Udani. In line with SEBI regulations, 25% of the issue price was paid at the time of allotment, with the remaining 75% now fully received.

This development underlines the promoters’ continued confidence in Veefin’s long-term strategy and further strengthens the Company’s capital position to drive its next phase of growth.

Strengthening the Balance Sheet for Strategic Expansion

This infusion enhances Veefin’s financial flexibility, allowing for accelerated investments in platform innovation, international market expansion, and ongoing strategic consolidation. With an API-first product suite and growing global client base, Veefin is well-positioned to scale sustainably while delivering high-impact, modular solutions across the working capital finance ecosystem.

Sustained Momentum Following Group Consolidation Plans:

The capital infusion follows Veefin’s recent announcement to consolidate its subsidiaries—Estorifi and GlobeTF—under the parent entity. This strategic move aims to unify the Company’s offerings across supply chain finance, digital lending, embedded finance, trade finance, and cash management.

Together, these initiatives reflect Veefin’s clear direction and preparedness to lead in the evolving global fintech landscape.

Mr. Raja Debnath, Chairman & Managing Director of Veefin Solutions Limited, said:

“Veefin is entering a phase of transformative growth. This capital infusion reflects our unwavering commitment to building a global platform that delivers exceptional value to clients and stakeholders alike. It enables us to scale with purpose and set new benchmarks in the industry.”

Mr. Gautam Udani, COO & Whole-Time Director, added:

“This milestone reaffirms our belief in the business and its future. The additional capital equips us to move faster, innovate deeper, and strengthen our mission of digitally transforming working capital ecosystems across markets.”

If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.

Business

Women in Manufacturing: Breaking Barriers Through Skill Development

New Delhi [India], July 14: For decades, manufacturing has been viewed as a male-dominated industry. But the factory of today looks very different from the factory of the past. Automation, robotics, AI, electric vehicles, and digital manufacturing are transforming shop floors across India. Success in modern manufacturing depends less on physical strength and more on […]

Read More
#IIoT automation expo Business Cybersecurity exhibition Industrial Automation manufacturing Mumbai Robotics

Automation Expo 2026 to Spotlight AI, Smart Manufacturing, and Industrial Innovation in Mumbai

Mumbai (Maharashtra) [India], July 14: Automation Expo 2026, one of India’s largest exhibitions dedicated to industrial automation, instrumentation, robotics, and digital transformation, will be held from July 22 to 25 at the Bombay Exhibition Centre, Mumbai. Organised by IED Communications Ltd., the four-day event is expected to host more than 700 exhibitors, bringing together manufacturers, […]

Read More
Business

Chandan Healthcare Limited Q1 FY27 Operational Update: Operating Income Up 35.64% YoY to ₹48.67 Cr; Pharmacy Up 13.69% YoY to ₹32.33 Cr

Lucknow (Uttar Pradesh) [India], July 14: Chandan Healthcare Limited (NSE – CHANDAN), – Chandan Healthcare Limited, one of India’s leading diagnostic healthcare providers with a rapidly expanding pan-India presence, today announced its operational update for the quarter ended June 30, 2026. Chandan Healthcare Limited reported unaudited operating income of ₹48.67 Cr in Q1 FY27, compared with ₹35.88 Cr in Q1 FY26, registering […]

Read More